肝癌经动脉内化疗栓塞（TACE）始于80年代初期，国内较大的医疗中心多数于1985年前后相继开展了这项治疗，目前是介入治疗领域中最活跃的分支。现综合文献及我们的经验谈几点体会。一、介入治疗效果肯定原发性肝癌是常见的恶性肿瘤，每年全球约125万人死于此症。我国是原发性肝 Liver cancer transcatheter arterial embolization (TACE) began in the early 1980s, and most of the country’s larger medical centers began this therapy in 1985 and are currently the most active branches in the field of interventional therapy. The comprehensive literature and our experience speak of a few experiences. First, the effect of interventional treatment is definitely common liver cancer is a common malignant tumor, about 1.25 million people die of this disease each year. China is a primary liver